(2025). Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes. Endocrine Regulations.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Mitochondria-targeting Compounds for Management of Metabolic and Hemostatic Abnormalities Associated with Heart Dysfunctions in Experimental Type 2 Diabetes."
Endocrine Regulations 2025.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Mitochondria-targeting Compounds for Management of Metabolic and Hemostatic Abnormalities Associated with Heart Dysfunctions in Experimental Type 2 Diabetes."
Endocrine Regulations, 2025.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.